BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 1720806)

  • 1. The insulin-like growth factors and their binding proteins in a case of non-islet-cell tumour-associated hypoglycaemia.
    Cotterill AM; Holly JM; Davies SC; Coulson VJ; Price PA; Wass JA
    J Endocrinol; 1991 Nov; 131(2):303-11. PubMed ID: 1720806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The differential regulation of the circulating levels of the insulin-like growth factors and their binding proteins (IGFBP) 1, 2 and 3 after elective abdominal surgery.
    Cotterill AM; Mendel P; Holly JM; Timmins AG; Camacho-Hübner C; Hughes SC; Ross RM; Blum WF; Langford RM
    Clin Endocrinol (Oxf); 1996 Jan; 44(1):91-101. PubMed ID: 8706300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The insulin-like growth factor (IGF)-binding proteins and IGF bioactivity in Laron-type dwarfism.
    Cotterill AM; Holly JM; Taylor AM; Davies SC; Coulson VJ; Preece MA; Wass JA; Savage MO
    J Clin Endocrinol Metab; 1992 Jan; 74(1):56-63. PubMed ID: 1370165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exercise-induced changes in insulin-like growth factors and their low molecular weight binding protein in healthy subjects and patients with growth hormone deficiency.
    Bang P; Brandt J; Degerblad M; Enberg G; Kaijser L; Thorén M; Hall K
    Eur J Clin Invest; 1990 Jun; 20(3):285-92. PubMed ID: 1695151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoglycaemia associated with the production of insulin-like growth factor II and insulin-like growth factor binding protein 6 by a haemangiopericytoma.
    Hoekman K; van Doorn J; Gloudemans T; Maassen JA; Schuller AG; Pinedo HM
    Clin Endocrinol (Oxf); 1999 Aug; 51(2):247-53. PubMed ID: 10468998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of endogenous insulin secretion regulates the rapid rise of insulin-like growth factor binding protein (IGFBP)-1 levels following acute hypoglycaemia.
    Cotterill AM; Holly JM; Amiel S; Wass JA
    Clin Endocrinol (Oxf); 1993 Jun; 38(6):633-9. PubMed ID: 7687525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concentrations, release, and disposal of insulin-like growth factor (IGF)-binding proteins (IGFBP), IGF-I, and growth hormone in different vascular beds in patients with cirrhosis.
    Møller S; Juul A; Becker U; Flyvbjerg A; Skakkebaek NE; Henriksen JH
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1148-57. PubMed ID: 7536200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of hepatoma associated with hypoglycaemia and overproduction of IGF-II (E-21): beneficial effects of treatment with growth hormone and intrahepatic adriamycin.
    Hunter SJ; Daughaday WH; Callender ME; McKnight JA; McIlrath EM; Teale JD; Atkinson AB
    Clin Endocrinol (Oxf); 1994 Sep; 41(3):397-401; discussion 402. PubMed ID: 7525121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of recombinant human insulin-like growth factor-I treatment on growth hormone secretion in two subjects with growth hormone insensitivity (Laron syndrome).
    Cotterill AM; Camacho-Hübner C; Holly JM; Savage MO
    Clin Endocrinol (Oxf); 1993 Jul; 39(1):119-22. PubMed ID: 7688671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of dexamethasone treatment on immunoreactive and bioactive insulin-like growth factors (IGFs) and IGF-binding proteins in normal male volunteers.
    Miell JP; Taylor AM; Jones J; Holly JM; Gaillard RC; Pralong FP; Ross RJ; Blum WF
    J Endocrinol; 1993 Mar; 136(3):525-33. PubMed ID: 7682595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factors (IGF) I and II and IGF binding proteins 1, 2 and 3 during low-dose growth hormone (GH) infusion and sequential euglycemic and hypoglycemic glucose clamps: studies in GH-deficient patients.
    Jørgensen JO; Blum WF; Horn N; Møller N; Møller J; Ranke MB; Christiansen JS
    Acta Endocrinol (Copenh); 1993 Jun; 128(6):513-20. PubMed ID: 7687807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversible effects of cessation and recommencement of thyroxine treatment on insulin-like growth factors (IGFs) and IGF-binding proteins in patients with total thyroidectomy.
    Miell JP; Zini M; Quin JD; Jones J; Portioli I; Valcavi R
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1507-12. PubMed ID: 7525638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of subcutaneous insulin-like growth factor-I infusion in insulin-dependent diabetes mellitus.
    Bach MA; Chin E; Bondy CA
    J Clin Endocrinol Metab; 1994 Oct; 79(4):1040-5. PubMed ID: 7525624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of hypothyroidism and hyperthyroidism on insulin-like growth factors (IGFs) and growth hormone- and IGF-binding proteins.
    Miell JP; Taylor AM; Zini M; Maheshwari HG; Ross RJ; Valcavi R
    J Clin Endocrinol Metab; 1993 Apr; 76(4):950-5. PubMed ID: 7682563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response of insulin-like growth factor (IGF)-binding protein-1 (IGFBP-1) and IGFBP-3 to IGF-I treatment in severe insulin resistance.
    Quin JD; Checkley A; Gallagher A; Jones J; MacCuish AC; Miell JP
    J Endocrinol; 1994 Apr; 141(1):177-82. PubMed ID: 7516962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factors-I and -II and their binding proteins during postnatal development of dwarf Snell mice before and during growth hormone and thyroxine therapy.
    van Buul-Offers SC; Bloemen RJ; Reijnen-Gresnigt MG; van Leiden HA; Hoogerbrugge CM; Van den Brande JL
    J Endocrinol; 1994 Oct; 143(1):191-8. PubMed ID: 7525829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effects of insulin-like growth factor (IGF)-I treatment on serum IGFs and IGF binding proteins in adolescent patients with growth hormone receptor deficiency.
    Wilson KF; Fielder PJ; Guevara-Aguirre J; Cohen P; Vasconez O; Martinez V; Martinez A; Rosenbloom AL; Rosenfeld RG
    Clin Endocrinol (Oxf); 1995 Apr; 42(4):399-407. PubMed ID: 7538453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregnancy in growth hormone-deficient rats: assessment of insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs) and IGFBP protease activity.
    Gargosky SE; Nanto-Salonen K; Tapanainen P; Rosenfeld RG
    J Endocrinol; 1993 Mar; 136(3):479-89. PubMed ID: 7682593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of recombinant human insulin-like growth factor I (IGF-I) therapy on the growth hormone-IGF system of a patient with a partial IGF-I gene deletion.
    Camacho-Hübner C; Woods KA; Miraki-Moud F; Hindmarsh PC; Clark AJ; Hansson Y; Johnston A; Baxter RC; Savage MO
    J Clin Endocrinol Metab; 1999 May; 84(5):1611-6. PubMed ID: 10323388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral contraceptives increase insulin-like growth factor binding protein-1 concentration in women with polycystic ovarian disease.
    Suikkari AM; Tiitinen A; Stenman UH; Seppälä M; Laatikainen T
    Fertil Steril; 1991 May; 55(5):895-9. PubMed ID: 1708731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.